On January 26, the US Food and Drug Administration halted the emergency use authorization of Evusheld because it does not appear to protect against Covid-19 from viral variants currently circulating in the United States.
Mandatory Credit: AstraZeneca
Stories this photo appears in:
With rise of new coronavirus variants, FDA halts authorization of Evusheld
The US Food and Drug Administration on Thursday halted the emergency use authorization of Evusheld because it does not appear to protect against Covid-19 from viral variants currently circulating in the United States.
